Logo for AxoGen Inc

AxoGen Investor Relations Material

Latest events

Logo for AxoGen Inc

Q4 2023

AxoGen
Logo for AxoGen

Q4 2023

5 Mar, 2024
Logo for AxoGen

Q3 2023

7 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from AxoGen Inc

Access all reports
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for peripheral nerve injury. It provides Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector that is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector that is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. The company also offers Avive Soft Tissue Membrane that is a processed human umbilical cord membrane used as a resorbable barrier to separate tissues in repair or reconstruction procedures; and AcroVal Neurosensory & Motor Testing System.